Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Treasury Shares (2016 - 2025)

Cumberland Pharmaceuticals' Treasury Shares history spans 16 years, with the latest figure at $58947.0 for Q4 2025.

  • For Q4 2025, Treasury Shares fell 82.62% year-over-year to $58947.0; the TTM value through Dec 2025 reached $58947.0, down 82.62%, while the annual FY2025 figure was $58947.0, 82.62% down from the prior year.
  • Treasury Shares for Q4 2025 was $58947.0 at Cumberland Pharmaceuticals, up from $3310.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $568181.0 in Q4 2021 and bottomed at $1800.0 in Q2 2025.
  • The 5-year median for Treasury Shares is $174149.0 (2022), against an average of $198824.8.
  • The largest annual shift saw Treasury Shares skyrocketed 89.86% in 2022 before it tumbled 98.8% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $568181.0 in 2021, then crashed by 30.35% to $395751.0 in 2022, then dropped by 23.58% to $302450.0 in 2023, then grew by 12.15% to $339200.0 in 2024, then plummeted by 82.62% to $58947.0 in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Treasury Shares are $58947.0 (Q4 2025), $3310.0 (Q3 2025), and $1800.0 (Q2 2025).